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Expression of the 11b-hydroxysteroid dehydrogenase 2 gene transcription factors [5, 6] that upon ligand binding homo-
in the mouse. Aldosterone acts via mineralocorticoid receptors dimerize, translocate to the nucleus and bind to specific
(MRs) to control salt and water flux in epithelial organs such
DNA sequences to modulate target gene transcription.as the kidney and colon to maintain circulatory homeostasis.
The action of glucocorticoids in specific tissues is mod-Inappropriate glucocorticoid-mediated activation of MRs in
aldosterone-target tissues is prevented by the glucocorticoid- ulated by the activity of the enzyme 11b-hydroxysteroid
metabolizing enzyme 11b-hydroxysteroid dehydrogenase type dehydrogenase, which interconverts cortisol in humans
2 (HSD2). We have studied HSD2 expression in the mouse at
and corticosterone in rodents to their inactive 11-ketothe level of gene transcription and further analyzed, with
metabolites [7]. Two enzyme isoforms exist. The first isHSD1, its pattern of tissue-restricted gene expression. The
mouse HSD2 gene, including upstream regulatory regions, has called 11b-hydroxysteroid dehydrogenase type-1 (HSD1),
been cloned, and its transcription start site has been mapped which converts 11-keto forms to active glucocorticoids,in colon and kidney. A 2.5 kb upstream region has been se-
and the second is 11b-hydroxysteroid dehydrogenasequenced, and its proximal promoter region has been analyzed.
We have compared the relative expression of HSD1 and HSD2 type 2 (HSD2), which inactivates glucocorticoids. In al-
in a variety of tissues from male mice using ribonuclease protec- dosterone target tissues, HSD2 activity prevents the
tion analysis. HSD1 was expressed in liver, kidney, adrenal,
higher circulating levels of glucocorticoids from activat-lung, spleen, thymus, fat, small intestine, stomach, heart, skin,
ing MR and thus mimicking aldosterone action. HSD1and epididymis. HSD2 was expressed in kidney, colon, small
intestine, stomach, and epididymus. No expression of either is expressed strongly in the liver, kidney, ovary, and fat
HSD1 and HSD2 was detected in bladder, testis, seminal vesi- [8, 9] and HSD2 in the kidney, colon, placenta, and
cles, vas deferens, prostate, or skeletal muscle. Finally, to inves-
parotid gland [10, 11]. The cDNA and genes for bothtigate the specific roles of HSD2 in vivo, we have created
HSD1 and HSD2 have now been cloned in a number of“floxed” HSD2 alleles using gene targeting in mouse embryonic
stem cells with the aim to create tissue-specific ablation of mammalian species [7]. Null mutations in the human
HSD2 in mice via Cre recombinase mediated gene targeting. HSD2 gene cause the rare and often fatal condition of
apparent mineralocorticoid excess, or AME [12]. Both
HSD1 and HSD2 genes have been knocked out in miceThe mineralocorticoid aldosterone is secreted from
[13, 14], with HSD1-deficient mice displaying subtle de-the adrenal to regulate salt and water flux in epithelial
fects in hepatic control of gluconeogenesis and HSD2-organs such as the kidney and the colon, and thereby in
deficient mice showing a 50% lethality 48 hours afterpart to regulate systemic blood pressure [1]. Glucocorti-
birth because of motor weakness, with the remaindercoids are important in the regulation of many develop-
developing symptoms similar to AME in humans. HSD2mental and homeostatic processes such as lung maturation,
has also been shown to be expressed in some nonminer-gluconeogenesis, and responses to stress [2]. Mineralo-
alocorticoid tissues such as discrete regions of the braincorticoid and glucocorticoid actions are mediated through
two specific intracellular receptors, the glucocorticoid and the stomach, where its role may be to exclude gluco-
receptor (GR) and the mineralocorticoid receptor (MR), corticoids [15]. To explore the molecular basis of the
the latter functioning as the physiological receptor for restricted expression of HSD2, we have cloned the up-
aldosterone [3, 4]. Both GR and MR are members of the stream regulatory region of the mouse HSD2 gene for
nuclear hormone receptor superfamily of ligand-activated further analysis. We have studied the expression of
HSD2 and HSD1 in a wide variety of mouse tissues using
a sensitive ribonuclease protection assay. Finally, we haveKey words: HSD2, gene targeting, steroid hormone receptors, mouse,
homeostasis. begun studies to inactivate the HSD2 gene in specific
cell types in mice using the loxP-Cre recombinase system.Ó 2000 by the International Society of Nephrology
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Fig. 1. DNA sequence and transcription start-
site mapping of the mouse HSD2 gene pro-
moter. (A) DNA sequence of 500 nucleotides
upstream of the mouse HSD2 gene (M) and
sequence comparison with the human HSD2
gene (H), including part of exon 1. The ATG
translation start in exon 1 is boxed. Binding
sites in the human HSD2 sequence for the SP1
transcription factor are boxed. Transcription
start sites in both the mouse (B) and human
(18) HSD2 sequences are indicated by stars.
(B) Mapping of transcription start sites for the
mouse HSD2 gene. Total RNA (15 mg) from
liver, kidney, and colon (in duplicate) was in-
cubated with a 460 nucleotide Sma I-Pst I
HSD2 antisense riboprobe (Probe) from the
proximal promoter region, including part of
exon 1. Yeast tRNA (tRNA) was incubated
as a negative control. Protected fragments of
approximately 180 nucleotides were detected
for kidney and colon only.
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primer sites (240 M13 primer and/or M13 reverse
primer). DNA sequences from these fragments were ob-
tained by automated sequencing on an ABI PRISMe
377 DNA Sequencer (Perkin Elmer, Norwalk, CT,
USA), and the final DNA sequence of the 2.4 kb pro-
moter region was determined on both strands by overlap-
ping individual DNA sequences.
Transcription start site mapping
Transcription start sites of the mouse HSD2 gene were
determined by RNase protection assay (as described
later in this article) with an antisense 460 bp Pst I-Sma
I RNA probe covering part of exon 1 and the 59 upstream
region. Total RNA (15 mg) from C57BL/6 mouse liver,
kidney, and colon was incubated with the 32P-labeled
probe overnight at 568C. Protected fragments were ana-
lyzed on a 6% denaturating polyacrylamide gel with la-
beled size markers.
Ribonuclease protection assay
Ribonuclease protection assays were performed as
previously described [17]. Antisense 32P-labeled RNA
probes were generated by in vitro transcription using
either T3 or T7 RNA polymerase. Probes for HSD1 and
HSD2 were derived from pBluescript (M131; Stra-
tagene) plasmids containing either a 270 nucleotide Xba
I cDNA fragment encompassing mouse HSD1 exons 4
to 6 or a 320 nucleotide StyI-EcoRI fragment from exon 5
of the mouse HSD2 gene [16]. Protected RNA fragments
were analyzed on 8% polyacrylamide/8.3 mol/L urea gels
with 32P-end-labeled 1 kb DNA ladder from GIBCO/
BRL (Gaithersburg, MA, USA) as size markers. Gels
were dried and exposed to x-ray (XAR; Kodak, Roches-
ter, NY, USA) film overnight at 2708C.
Isolation of total RNA
Total RNA was prepared from isolated mouse tissues
by homogenization in TRIzole reagent (GIBCO BRL),
a guanidinium isothiocyanate/phenol-based homogeni-
zation solution. After chloroform extraction, RNA was
precipitated from the aqueous phase with isopropanolFig. 1. (Continued)
and was washed in 70% ethanol and redissolved in
nuclease free sterile water.
METHODS Construction of a HSD2 CRE-LoxP targeting vector
Cloning of the mouse HSD2 promoter region and For conditional Cre recombinase-mediated gene tar-
DNA sequencing geting, a 2.4 kb Xba I fragment containing exons 2
through 5 of the mouse gene HSD2 was flanked by twoA 4.2 kb gene fragment containing the promoter re-
Cre recombinase lox P binding sites (Fig. 3). An adjacentgion of the mouse 11b-HSD2 gene was isolated from a
39 2.8 kb Xba I fragment was inserted and used as thelDash II bacteriophage containing the entire mouse 11b-
39 region of homology for homologous recombination.HSD2 gene [16] and was cloned into the pBluescribe
A 4 kb Xba I fragment 59 to the exon 2-5 Xba I fragment(Stratagene, La Jolla, CA, USA). Following 59 deletion
was selected as the 59 region of homology for homolo-using the Erase-a-base system (Promega, Madison, WI,
gous recombination. This 4 kb Xba I fragment was in-USA), eight plasmids containing smaller inserts were
generated to facilitate DNA sequencing from single serted into the Xba I site of a plasmid, which contained
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Fig. 2. Tissue expression profile of mouse HSD1 and HSD2 by RNase protection assay. Expression of HSD1 and HSD2 mRNA was detected by
RNase protection in total RNA using 32P-labeled antisense probes for HSD1, a 270-bp Xba I cDNA fragment encompassing exons 4 through 6,
HSD2, and a 320 bp Sty I-EcoRI fragment from exon 5. Total RNA (10 mg) from various tissues was incubated with both probes (Probe) together
overnight at 568C. Yeast tRNA (tRNA) was incubated as a negative control, and size marker (M) was end labeled 1 kb ladder (GIBCO BRL).
a single lox P site followed by a neor–5HSV-tk gene tion start sites for mouse HSD2 were determined by
cassette. This modified plasmid was digested with SacI RNase protection assay with total RNA from kidney
(blunt filled) and Not I and ligated with the fragment and colon (Fig. 1B). Start sites for transcription (shown
described earlier in this article containing the two Xba by stars in Fig. 1A) were mapped approximately 110
I fragments with two lox P sites. The final Cre-lox P nucleotides 59 to the translation ATG, identical for kid-
DNA construct was linealized with Not I and 20 mg ney and colon, and corresponding to a similar start site
transfected by electroporation into mouse embryonic mapped for the human HSD2 gene in kidney [18]. Unlike
stem (ES) cells. the human HSD2 promoter, the mouse promoter con-
tains a TATA box approximately 30 nucleotides up-
stream of its transcription start sites. Preliminary trans-RESULTS
fection experiments in the mouse M1 collecting ductTo analyze the upstream regions controlling the tissue-
cell line, using a luciferase reporter gene with 59-deletedspecific expression of the mouse HSD2 gene, we cloned
regions of the mouse HSD2 upstream region, indicateand sequenced a 2.4 kb Eco RI-Xho I fragment located
that only the proximal 286 nucleotides is required for full59 to exon 1 of the mouse HSD2 gene. A 500 nucleotide
activity of the mouse HSD2 promoter (data not shown).region of DNA sequence upstream of exon 1 is shown
To further explore the restricted expression patternin Figure 1A, where it is compared with the homologous
of HSD2 and HSD1, we performed a simultaneous ribo-region in the human HSD2 gene [18]. There is an overall
nuclease protection assay for both HSD1 and HSD2sequence homology of 75%, with almost 100% of se-
transcripts in total RNA from a wide variety of tissuesquence conservation in exon 1 after the translation start
from male mice (Fig. 2). HSD1 was strongly expressedATG. Two functional SP1 sites mapped in the promoter
in total RNA from liver, kidney, stomach, lung, and fat.region of the human HSD2 gene are boxed, but only the
distal SP1 site is conserved in the mouse. The transcrip- We also detected strong expression in total RNA from
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Fig. 3. Targeting strategy for tissue-specific gene targeting of the mouse HSD2 gene. The neomycin resistance gene (neor), the thymidine kinase
gene (TK), and three 34 bp lox P binding sites (arrows) were inserted into the mouse HSD2 gene (mHSD2) to produce a conditional targeting
vector for introduction into mouse ES cells. Probe A (0.7 kb BglII-PvuII fragment) and probe B (1.4 kb Xba I fragment) are single copy probes
for Southern analysis of Eco RI/BamHI and Hind III enzyme digests of genomic DNA, respectively. Exons 1 through 5 of the HSD2 gene are
shown as filled boxes.
spleen and thymus, and weak expression in adrenal, small sequences in between two Lox P binding sites. It is hoped
intestine, stomach, and epididymis. HSD2 was strongly to use these ES cells to produce a HSD2 lox P flanked
expressed in kidney and colon as expected, with lower mouse (or “floxed” mouse, which will be otherwise nor-
levels of expression in small intestine, stomach, and epi- mal), and then cross this with a Cre recombinase mouse
didymis. Very low levels of expression were detected in expressing the recombinase in a tissue-specific fashion
total RNA from lung, thymus, and spleen. All other (for example, in the brain to produce brain HSD2-tar-
mouse tissues tested were negative for HSD2 at this level geted knockout mice).
of sensitivity. No expression of either HSD1 and HSD2
was detected in bladder, testis, seminal vesicles, vas def-
DISCUSSIONerens, prostate, or skeletal muscle.
We have cloned the promoter and upstream region ofA total gene knockout of HSD2 in mice produces a
the mouse HSD2 gene in order to analyze the transcrip-mixed phenotype with 50% lethality at birth [14], with
tional mechanism of tissue-specific expression. The se-surviving mutant mice having a dramatic phenotype pri-
quence of the proximal promoter is highly homologousmarily caused by abnormalities in renal and colonic han-
(up to 75%) to that of the human HSD2 gene [18] anddling of sodium. To address the role of HSD2 in glucocor-
correlates with a similar tissue expression pattern. Unliketicoid modulation in individual HSD2 expressing tissues,
the human promoter, the mouse HSD2 promoter con-such as the brain, we are using conditional gene targeting
tains a TATA box 30 nucleotides upstream of its tran-[19] to allow production of tissue or cell-type–specific
scription start sites mapped in kidney and colon. Of twotargeted HSD2 mice (Fig. 3). In mouse ES cells, we have
functional Sp1 sites in the human promoter, only oneused homologous recombination to position 34 bp lox P
such site is conserved in the mouse. The Sp1 transcriptionbinding sites in the intron before exon 2 and after exon
5 (Fig. 3). Expression of the Cre recombinase will delete factor, however, is ubiquitously expressed and more
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